TNF antagonist therapy for gastrointestinal acute graft-versus-host disease refractory to steroid in allogeneic haematopoietic cell transplantation

被引：0
|
作者：
Shimazu, H. [1 ]
Tsuji, M. [1 ]
Ishiwata, K. [1 ]
Nakano, N. [1 ]
Yamamoto, H. [1 ]
Asano-Mori, Y. [1 ]
Uchida, N. [1 ]
Masuoka, K. [1 ]
Wake, A. [1 ]
Makino, S. [1 ]
Yoneyama, A. [1 ]
Taniguchi, S. [1 ]
机构：
[1] Toranomon Gen Hosp, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S390 / S390
页数：1
相关论文
共 50 条
  • [31] Extracorporeal photochemotherapy treatment of steroid refractory or hyperacute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation from matched unrelated donors
    Reti, M.
    Remenyi, P.
    Barta, A.
    Batai, A.
    Csukly, Z.
    Goda, V.
    Gopcsa, L.
    Lengyel, L.
    Rasonyi, R.
    Torbagyi, E.
    Masszi, T.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S159 - S159
  • [32] Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Jan, Anna
    Shigle, Terri Lynn
    Wang, Emily
    Nieto, Yago
    Ciurea, Stefan O.
    Oran, Betul
    Im, Jin
    Olson, Amanda
    Marin, David
    Qazilbash, Muzaffar
    Khouri, Issa
    Rondon, Gabriela
    Anderlini, Paolo
    Rezvani, Katayoun
    Popat, Uday
    Kebriaei, Partow
    Shpall, Elizabeth
    Champlin, Richard
    Alousi, Amin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 272.e1 - 272.e5
  • [33] Computed tomography imaging of acute gastrointestinal graft-versus-host disease after haematopoietic stem cell transplantation in children
    Arpaci, Taner
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (03): : 178 - 183
  • [34] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    Massenkeil, G
    Rackwitz, S
    Genvresse, I
    Rosen, O
    Dörken, B
    Arnold, R
    BONE MARROW TRANSPLANTATION, 2002, 30 (12) : 899 - 903
  • [35] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    G Massenkeil
    S Rackwitz
    I Genvresse
    O Rosen
    B Dörken
    R Arnold
    Bone Marrow Transplantation, 2002, 30 : 899 - 903
  • [36] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
  • [37] HLA allele associations with graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
    Kitra, V
    Moraloglou, O
    Petra, F
    Spanou, K
    Peristeri, I
    Gousetis, E
    Delikou, S
    Constantinidou, N
    Graphakos, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S137 - S138
  • [38] Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation
    Yamane, T
    Yamamura, R
    Aoyama, Y
    Nakamae, H
    Hasegawa, T
    Sakamoto, C
    Shibata, H
    Terada, Y
    Koh, G
    Hino, M
    LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2095 - 2097
  • [39] Clinical aspects of sclerodermoid type graft-versus-host disease after allogeneic haematopoietic cell transplantation
    Sanly, H
    Akay, N
    Soydan, E
    Kocyigit, P
    Arat, M
    Ilhan, O
    BONE MARROW TRANSPLANTATION, 2006, 37 : S96 - S96
  • [40] Graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in children and adolescents with thalassemia
    Pakakasama, S.
    Klamchuen, S.
    Hongeng, S.
    Sirireung, S.
    Anurathapan, U.
    Songdej, D.
    Sasinil, S.
    Sirachainan, N.
    Chuansumrit, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S285 - S285
12345